Comparison of the antibacterial activities of ampicillin, ciprofloxacin, clarithromycin, telithromycin and quinupristin/dalfopristin against intracellular non-typeable Haemophilus influenzae

被引:22
作者
Ahrén, IL [1 ]
Karlsson, E [1 ]
Forsgren, A [1 ]
Riesbeck, K [1 ]
机构
[1] Lund Univ, Malmo Univ Hosp, Dept Med Microbiol, S-20502 Malmo, Sweden
关键词
D O I
10.1093/jac/dkf221
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Non-typeable Haemophilus influenzae, which is a cause of disease in the upper and lower respiratory tract, can survive intracellularly in human epithelial cells and macrophages. We studied the in vitro activity of five antibiotics against intracellular non-typeable H. influenzae in human type II alveolar epithelial cells. The eukaryotic cells were loaded with bacteria, and extracellular bacteria were killed by gentamicin. After the cells were washed, antibiotics were added at concentrations of 0.12-64 mg/L for 18 h before the numbers of viable intracellular bacteria were determined. Of the antibiotics tested, ciprofloxacin and quinupristin/dalfopristin were the most potent agents, followed by clarithromycin and telithromycin. Ampicillin was not active against intracellularly localized, non-typeable H. influenzae.
引用
收藏
页码:903 / 906
页数:4
相关论文
共 24 条
[1]   The importance of a β-glucan receptor in the nonopsonic entry of nontypeable Haemophilus influenzae into human monocytic and epithelial cells [J].
Ahrén, IL ;
Williams, DL ;
Rice, PJ ;
Forsgren, A ;
Riesbeck, K .
JOURNAL OF INFECTIOUS DISEASES, 2001, 184 (02) :150-158
[2]  
Amsden GW, 2001, INT J ANTIMICROB AG, V18, pS11, DOI 10.1016/S0924-8579(01)00410-1
[3]  
Brown K N, 1978, Scand J Infect Dis Suppl, P251
[4]   Ketolides - telithromycin, an example of a new class of antibacterial agents [J].
Bryskier, A .
CLINICAL MICROBIOLOGY AND INFECTION, 2000, 6 (12) :661-669
[5]   Multiple-dose pharmacokinetics and safety of two regimens of quinupristin/dalfopristin (Synercid®) in healthy volunteers [J].
Chevalier, P ;
Rey, J ;
Pasquier, O ;
Rouzier-Panis, R ;
Harding, N ;
Montay, G .
JOURNAL OF CLINICAL PHARMACOLOGY, 2001, 41 (04) :404-414
[6]   Quinupristin-dalfopristin: An overview [J].
Delgado, G ;
Neuhauser, MM ;
Bearden, DT ;
Danziger, LH .
PHARMACOTHERAPY, 2000, 20 (12) :1469-1485
[7]   CELLULAR UPTAKE AND INTRACELLULAR BACTERICIDAL ACTIVITY OF RP 59500 IN MURINE MACROPHAGES [J].
DESNOTTES, JF ;
DIALLO, N .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1992, 30 :107-115
[8]   Antibiotics in the treatment of acute exacerbations of chronic bronchitis [J].
Dever, LL ;
Shashikumar, K ;
Johanson, WG .
EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2002, 11 (07) :911-925
[9]  
DHOOGE J, 2002, INT J PEDIATR OTORHI, V54, P7
[10]   Pharmacodynamic and pharmacokinetic considerations in antimicrobial selection: focus on telithromycin [J].
Drusano, G .
CLINICAL MICROBIOLOGY AND INFECTION, 2001, 7 :24-29